SilverSun Technologies Remains Competitive in the Business Solutions Market with LOI Announcement

Spotlight Companies  |

With new innovations being developed and manufactured in the technology sector, there is a wide variety of software solutions that streamline a variety of business operations that include everything from payroll to operations and back office functions. In order to stay ahead of this ever-evolving market, strategy and solutions companies will often seek to acquire already existing companies that already utilize their desired technology is already, instead of using their own resources to develop new software. SilverSun Technologies Inc. ($SSNT) is one such company looking to stay ahead of the competition with their latest business move.

On Friday, SWK Technologies, a wholly owned subsidiary of SilverSun Technologies, announced its signing of a non-binding letter of intent (LOI) to acquire The Macabe Associates Inc. Although the terms of the transaction have not been disclosed, the deal, projected to add $1 million in annual revenue, is expected to be completed by September 30, 2015.

SWK Technologies is a business application and consulting company that provides information and business management solutions. In an effort to further serve their client’s business strategy and solution needs, SilverSun Technologies looks to acquire technology and software companies that allow it to compete in the business solutions marketplace. The move to acquire The Macabe Associates, a developer and reseller of Sage and Acumatica applications, is in line with SWK’s mission to stay competitive in this expanding market, while also increasing annual revenue.

“The Macabe Associates has an impressive library of proprietary solutions and integrations, and a strong, established customer base,” said, Mark Meller, CEO of SilverSun Technologies. “With our existing sales and marketing infrastructure, we believe we can substantially increase the revenue generated by these proprietary products. We continue to execute on our business plan to increase value for our shareholders by increasing profitable sales and acquiring companies and technologies.”

Planning for Future Growth by Investing in Software Development

Sage and Acumatica are both enterprise resource planning (ERP) softwares used to automate back office functions. “This acquisition further enhances SWK’s position within the Sage and Acumatica ecosystems,” said Jeffrey D. Roth, CEO of SWK Technologies. “Our management talent, in-house expertise, and financial resources will enable us to rapidly accelerate sales from the Macabe customer base. Furthermore, the addition of Mary Abdian and her team will provide us with additional development talent to create more proprietary applications and integrations.  We are very excited about this acquisition, and the opportunities it provides us for future growth."

By investing in development talent pioneered by a reputable company, SWK Technologies gets the best of both worlds. Planning ahead will establish SWK as a major player in providing solutions while keeping their stockholders happy with revenue growth.

For more information about SilverSun Technologies, visit

Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention the fact that, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update. Mr. Corin discusses the company's recent acquisition of Metastron, a radiopharmaceutical for cancer bone pain. Q BioMed is dedicated to providing these target assets; strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential, enabling them to provide products to patients in need?.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.